Evolocumab use in Greece is associated with early and sustainable reductions in low-density cholesterol (LDL-C) and high persistence to therapy: Results from the Greek cohort analysis of the observational HEYMANS study

Affiliations

• ¹ 1st Department of Cardiology, Medical School, National and Kapodistrian, University of Athens, Hippokration Hospital, Athens, Greece.
• ² Amgen Hellas, Athens, Greece. Electronic address: dmassia@amgen.com.
• ³ Cardiology Department, Heraklion University Hospital, Crete, Greece.
• ⁴ Cardiometabolic Center, Lipid Clinic, LA Apheresis Unit, Metropolitan Hospital, Athens, Greece.
• ⁵ Cardiology Department, General Hospital of Nea Ionia "Konstantopoulio", Athens, Greece.
• ⁶ Amgen UK Ltd, Uxbridge, UK.
• ⁷ Amgen (Europe) GmbH, Rotkreuz, Switzerland.
• ⁸ Amgen Inc, Thousand Oaks, USA.
• ⁹ First Department of Propaedeutic Internal Medicine, Medical School, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
• ¹⁰ Imperial Centre for Cardiovascular Disease Prevention and Imperial Clinical Trials Unit, Imperial College London, London, UK.